相关实验视频
Updated: Sep 9, 2025

11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
55.2K
[与败血症相关的扩散性血管内凝血]
1Medical Laboratory Sciences, School of Medicine, Kumamoto University.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|September 3, 2025
概括
败血症是由于感染而引起的器官功能障碍,导致血液凝固转移到前血栓性状态. 与抗血栓治疗一样,可以帮助控制与败血症相关的传播性血管内凝血 (DIC) 和器官损伤.
科学领域:
- 危急护理医学
- 血液学
- 传染性疾病
背景情况:
- 败血症是由于宿主对感染的反应失调而导致的危及生命的器官功能障碍.
- 传染病可以将原血栓/抗血栓平衡转移到原血栓状态,一个防御机制.
- 在严重的感染中,未被抑制的前血栓反应会导致与败血症相关的扩散性血管内凝血 (DIC) 和器官损伤.
研究的目的:
- 审查抗凝剂在治疗败血症相关的DIC中的作用.
- 突出目前日本临床实践指南的败血症和DIC管理.
- 确定有关败血症最佳抗凝血策略的进一步讨论领域.
主要方法:
- 审查当前的文献和临床实践指南.
- 与败血症相关的DIC的病理生理学分析.
- 对与败血症相关的DIC治疗建议的评估.
主要成果:
- 与败血症相关的DIC涉及到广泛的缺血器官损伤.
- 抗凝治疗可以缓解血相关的DIC中的缺血性器官损伤.
- 日本的指导方针建议使用抗血栓或复合血栓模块来治疗与败血症相关的DIC.
结论:
- 抗凝药是一种潜在的治疗策略与败血症相关的DIC.
- 目前的指导方针建议使用特定的治疗药物.
- 需要进行进一步的研究,以优化患者选择和治疗血症相关的DIC的方法.
相关概念视频
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K
Endocarditis II: Clinical Features of Infective Endocarditis
25
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K

